The present invention relates to novel indole derivatives which bind to the 5-HT2B receptor and are capable of interfering with the effects of 5-hydroxytryptamine (5-HT) at the 5-HT2B receptor; to processes for their preparation; to pharmaceutical compositions containing them; and to the use of such compounds in therapy.
本发明涉及新型
吲哚衍
生物,其结合到5-HT2B受体并能够干扰5-羟
色胺(5-HT)在5-HT2B受体上的作用;其制备过程;包含它们的制药组合物;以及在治疗中使用这些化合物的用途。